Re: ZHCLF trades on the OTC
in response to
by
posted on
Jan 18, 2021 12:06AM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
That makes sense, thanks for the response RVXoldtimer! The trading for ZHCLF has been very spuratic but very tempted to bid for more ;)